Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of Revision (Increase) of Interim Dividend and Year-End Dividend Forecasts for FY3/2026
Notice of Revision to Consolidated Financial Results Forecasts for the Second Quarter of the Fiscal Year Ending March 2026 and Full-Year Forecasts
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2025 (Based on Japanese GAAP)
FUSO CHEMICAL, Ordinary Profit Forecast for the Fiscal Year Revised Upward to an Unexpected 6% Increase, Dividend Revised Upward by 6 Yen
Announcement of Personnel Changes
Notice Regarding Completion of Allotment for Disposal of Treasury Stock as Restricted Stock Compensation
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2025 (Based on Japanese GAAP)
FUSO CHEMICAL, Apr-Jun (1Q) Ordinary Profit Increases by 6%
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation
Corporate Governance report
Announcement of Organizational and Personnel Changes
Summary of Consolidated Financial Results for the Year Ended March 31, 2025 (Based on Japanese GAAP)
Action to Implement Management that is Conscious of Cost of Capital and Stock Price(Update)
FUSO CHEMICAL, 17% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 3 yen
Announcement of Organizational and Personnel Changes
FUSO CHEMICAL, The Current Fiscal Year Ordinary Profit Revised Upward by 20%, Dividend Revised Upward by 3 yen
Announcement of Organizational Changes, Personnel Changes and Election of Candidates for Board Directors
Notice Concerning Revision to Full-Year Financial Results Forecasts and Dividends Forecasts for the Fiscal Year Ending March 31, 2025
FUSO CHEMICAL, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 51%, Oct-Dec Ordinary Profit Increases by 2.1 times
Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2024